Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP901553.RAbLtBNXqjtXV6RRuNDanq77-n_c-V4SdnQ5MYYavLRD0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP901553.RAbLtBNXqjtXV6RRuNDanq77-n_c-V4SdnQ5MYYavLRD0130_assertion type Assertion NP901553.RAbLtBNXqjtXV6RRuNDanq77-n_c-V4SdnQ5MYYavLRD0130_head.
- NP901553.RAbLtBNXqjtXV6RRuNDanq77-n_c-V4SdnQ5MYYavLRD0130_assertion description "[Supplementation with MAPK inhibitor (MEK inhibitor PD98059, p38 MAPK inhibitor SB203580 and JNK inhibitor SP600125) or Cariporide all exhibited significant depression of MDA-MB-231 cells invasion and MT1-MMP expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP901553.RAbLtBNXqjtXV6RRuNDanq77-n_c-V4SdnQ5MYYavLRD0130_provenance.
- NP901553.RAbLtBNXqjtXV6RRuNDanq77-n_c-V4SdnQ5MYYavLRD0130_assertion evidence source_evidence_literature NP901553.RAbLtBNXqjtXV6RRuNDanq77-n_c-V4SdnQ5MYYavLRD0130_provenance.
- NP901553.RAbLtBNXqjtXV6RRuNDanq77-n_c-V4SdnQ5MYYavLRD0130_assertion SIO_000772 21669197 NP901553.RAbLtBNXqjtXV6RRuNDanq77-n_c-V4SdnQ5MYYavLRD0130_provenance.
- NP901553.RAbLtBNXqjtXV6RRuNDanq77-n_c-V4SdnQ5MYYavLRD0130_assertion wasDerivedFrom befree-2016 NP901553.RAbLtBNXqjtXV6RRuNDanq77-n_c-V4SdnQ5MYYavLRD0130_provenance.
- NP901553.RAbLtBNXqjtXV6RRuNDanq77-n_c-V4SdnQ5MYYavLRD0130_assertion wasGeneratedBy ECO_0000203 NP901553.RAbLtBNXqjtXV6RRuNDanq77-n_c-V4SdnQ5MYYavLRD0130_provenance.